Lilly Again Looks to China for New Drugs, Paying InnoCare $100M to Start R&D Pact

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 24 Sept, 18:31 UTC

Eli Lilly’s partnership with InnoCare Pharma follows deals struck this year with other China-based companies. While indications for the new alliance remain undisclosed, InnoCare specializes in oncology and autoimmune drugs. The post Lilly Again Looks to China for New Drugs, Paying InnoCare $100M to…

science

Sources

• T2Lilly Again Looks to China for New Drugs, Paying InnoCare $100M to Start R&D PactFierce Biotech / Fierce Healthcare / MedCity / GEN24 Sept, 18:31